Multi-dimensional proteomic analyses provide different layers of protein information,
including protein abundance and post-translational modifications. Here, we report an …

Objective LC-MS/MS phospho-proteomics is an essential technology to help unravel the
complex molecular events that lead to and propagate cancer. We have developed a global …

Advancements in mass spectrometry (MS)-based proteomics have greatly facilitated the
large-scale quantification of proteins and microproteins, thereby revealing altered signalling …

Abstract We integrated LC-MS/MS-based and protein antibody array-based proteomics with
genomics approaches to investigate the phosphoproteome and transcriptome of gastric …

Large-scale omics studies have generated a wealth of mass spectrometry–based
proteomics data, which provide additional insights into disease biology spanning genomic …

Background Proteomic characterization of cancers is essential for a comprehensive
understanding of key molecular aberrations. However, proteomic profiling of a large cohort …

Breast cancer is one of the most common cancers in women worldwide. In the past decades,
many advances have been made in understanding and treating breast cancer. However …

Quantitative proteomics allows the characterization of molecular changes between healthy
and disease states. To interpret such datasets, their integration to the protein–protein …

Background The gastric cancer is one of the most common and mortal cancer worldwide.
The initial asymptomatic development and further nonspecific symptoms result in diagnosis …

Global proteomic data generated by advanced mass spectrometry (MS) technologies can
help bridge the gap between genome/transcriptome and functions and hold great potential …